Concepedia

Sandra Lord

SL

Statistics

Publications

16

Citations

649

H-Index

13

Active since

2015

Affiliations

Benaroya Research Institute(Current)

Yale University

Virginia Mason Medical Center

University of Colorado Anschutz Medical Campus

University of Florida

Sandra Lord is an author at Benaroya Research Institute specializing in diabetes mellitus, endocrinology, and immunology.

ORCID

Publications per year

2015–2023

16

Publications

16

Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data

Michael J. Haller, S. Alice Long, J. Lori Blanchfield et al. · Diabetes · 2019 · 131 citations · Full text

, , +17

Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial

William E. Russell, Brian N. Bundy, Mark S. Anderson et al. · Diabetes Care · 2023 · 96 citations · Full text

, , +16

IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes

Carla J. Greenbaum, Elisavet Serti, Katharina Lambert et al. · JCI Insight · 2021 · 58 citations · Full text

, , +13

CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study

Darrell M. Wilson, Susan L. Pietropaolo, Maria Acevedo-Calado et al. · Diabetes Care · 2023 · 51 citations · Full text

, , +16

SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity

Jillian R. Jaycox, Carolina Lucas, Yile Dai et al. · Nature Communications · 2023 · 46 citations · Full text

, , +17

1–5 of 16